Daiken Biomedical Co., Ltd.
Research Daiken Biomedical Co., Ltd. (7780.TW) on Bullrun: market cap TWD 12.93B, P/E 160.5, dividend yield 7.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7780.TW
- ExchangeTW
- CountryTaiwan
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyTWD
- Market capTWD 12.93B
- P/E160.5
- Dividend yield7.3%
- Financial periodQ2 2026
- RevenueTWD 616.34M
- Net incomeTWD 126.54M
- Free cash flowTWD 25.02M
- Gross margin62.1%
Valuation Snapshot
latest market cap is TWD 12.93B; P/E is 160.5; dividend yield is 7.3%.
Peer valuation comparison
Latest P/E is 160.5x versus a Consumer Defensive sector median of 16.8x (855.4% above).
Latest dividend yield is 7.25% versus a Consumer Defensive sector median of 2.98% (143.3% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 12.93B | 160.5 | 6.8% | 1.09 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.09 TWD, yield 7.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.89 TWD |
About Daiken Biomedical Co., Ltd.
Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Daiken Biomedical Co., Ltd.'s market cap?
Daiken Biomedical Co., Ltd.'s market capitalization is TWD 12.93B.
What is Daiken Biomedical Co., Ltd.'s P/E ratio?
Daiken Biomedical Co., Ltd.'s price-to-earnings (P/E) ratio is 160.5.
Does Daiken Biomedical Co., Ltd. pay a dividend?
Daiken Biomedical Co., Ltd. has a dividend yield of 7.3%.
What does Daiken Biomedical Co., Ltd. do?
Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.